Attention-Deficit/Hyperactivity Disorder clinical trials at UCSF
2 in progress, 0 open to eligible people
PDC-1421 Treatment in Adult Patients With ADHD
Sorry, currently not accepting new patients, but might later
Part II is a double-blind, randomized, parallel-group, placebo-controlled study. The primary objective of this trial is to determine the effective doses and treatment period of PDC-1421 Capsule in subjects with ADHD. The secondary objective is to evaluate the safety of PDC-1421 Capsule in subjects receiving PDC-1421 at various dose levels.
San Francisco, California and other locations
dHealth Solution for Improving Parent Adherence to Behavioral Treatment for ADHD
Sorry, accepting new patients by invitation only
This study aims to develop, refine and preliminarily test a novel and scalable digital health solution designed to address parent adherence barriers in daily life contexts and increase parent's sustained use of evidence-based parenting strategies.
San Francisco, California
Our lead scientists for Attention-Deficit/Hyperactivity Disorder research studies include Linda Pfiffner, PhD.
Last updated: